Adisseo says its second liquid methionine plant in Nanjing, China (180,000 t/yr nameplate) remains on track for a late H2 2022 start-up. Its Calysseo joint venture with Calysta expects its first FeedKind protein facility in Chongqing to start in 2022.
Future methionine capacity additions in China point to looser supply later, a bearish longer-term factor for methionine prices, while new protein alternatives could eventually compete with fishmeal and soy protein.
Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.